Richard E Lowenthal - Net Worth and Insider Trading
Richard E Lowenthal Net Worth
The estimated net worth of Richard E Lowenthal is at least $168 Million dollars as of 2024-11-29. Richard E Lowenthal is the PRESIDENT AND CEO, 10% Owner of ARS Pharmaceuticals Inc and owns about 11,565,600 shares of ARS Pharmaceuticals Inc (SPRY) stock worth over $168 Million. Details can be seen in Richard E Lowenthal's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard E Lowenthal has not made any transactions after 2024-11-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Richard E Lowenthal
Richard E Lowenthal Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard E Lowenthal owns 2 companies in total, including Silverback Therapeutics Inc (SBTX) , and ARS Pharmaceuticals Inc (SPRY) .
Click here to see the complete history of Richard E Lowenthal’s form 4 insider trades.
Insider Ownership Summary of Richard E Lowenthal
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SBTX | Silverback Therapeutics Inc | 2022-11-08 | director & 10 percent owner & President and CEO |
| SPRY | ARS Pharmaceuticals Inc | 2024-11-12 | director & 10 percent owner & President and CEO |
Richard E Lowenthal Latest Holdings Summary
Richard E Lowenthal currently owns a total of 1 stock. Richard E Lowenthal owns 11,565,600 shares of ARS Pharmaceuticals Inc (SPRY) as of November 19, 2024, with a value of $168 Million.
Latest Holdings of Richard E Lowenthal
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals Inc | 2024-11-19 | 11,565,600 | 14.53 | 168,048,168 |
Holding Weightings of Richard E Lowenthal
Richard E Lowenthal Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard E Lowenthal has made a total of 20 transactions in ARS Pharmaceuticals Inc (SPRY) over the past 5 years, including 0 buys and 20 sells. The most-recent trade in ARS Pharmaceuticals Inc is the sale of 100,000 shares on November 19, 2024, which brought Richard E Lowenthal around $1 Million.
Insider Trading History of Richard E Lowenthal
- 1
Richard E Lowenthal Trading Performance
Richard E Lowenthal Ownership Network
Richard E Lowenthal Owned Company Details
What does Silverback Therapeutics Inc do?
Who are the key executives at Silverback Therapeutics Inc?
Richard E Lowenthal is the director & 10 percent owner & President and CEO of Silverback Therapeutics Inc. Other key executives at Silverback Therapeutics Inc include Chief Operating Officer Brian Dorsey , Chief Legal Officer Alexander A Fitzpatrick , and Chief Financial Officer Kathleen D. Scott .
Silverback Therapeutics Inc (SBTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Silverback Therapeutics Inc (SBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Silverback Therapeutics Inc (SBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Silverback Therapeutics Inc (SBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Silverback Therapeutics Inc Insider Transactions
Richard E Lowenthal Mailing Address
Above is the net worth, insider trading, and ownership report for Richard E Lowenthal. You might contact Richard E Lowenthal via mailing address: 12481 High Bluff Drive, Suite 200, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
